Prilosec OTC Part Of “Engine Of Growth” P&G Expects From Health Care Sales
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble's Prilosec OTC (omeprazole) reached nearly 40 percent market share in the firm's latest quarter to lead the OTC heartburn medication segment